Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy

Immunotherapy has emerged as a promising approach to combat immunosuppressive tumor microenvironment (TME) for improved cancer treatment. FDA approval for the clinical use of programmed death receptor 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors revolutionized T cell-based immunotherapy. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeshakin, Adeleye O., Adeshakin, Funmilayo O., Yan, Dehong, Wan, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818783/
https://www.ncbi.nlm.nih.gov/pubmed/35140716
http://dx.doi.org/10.3389/fimmu.2022.781660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818783/
https://www.ncbi.nlm.nih.gov/pubmed/35140716
http://dx.doi.org/10.3389/fimmu.2022.781660

Ejemplares similares